AMEX: INO       Inovio Pharma
Last Price Today's Change   Day's Range   Trading Volume
10.816   -0.294 (2.65%)  10.32 - 10.89  3,300,380


Avg Volume (4 weeks):7,662,720
4 Weeks Range:10.28 - 13.11
4 Weeks Price Volatility (%):
52 Weeks Range:2.09 - 33.79
52 Weeks Price Volatility (%):
Average Price Target: 0.70
Price Target Upside/Downside: -10.116


No recent Headlines for this stock.

Business Background

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

  Be the first to like this.
selamba so good counter
05/08/2013 8:11 PM

I3 Messenger
Individual or Group chat with anyone on I3investor

1680  4302  267  3150 

Top 10 Active Counters
 MGEN 1.14+0.62 
 TTNP 0.206+0.078 
 GE 7.75+0.65 
 LK 1.38+1.38 
 AAPL 112.465-4.135 
 OAS 0.155-0.014 
 SQQQ 24.275+2.215 
 NIO 27.365-1.075 
 NAKD 0.086-0.006 
 AMD 76.78-2.10